Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

L19TNF plus doxorubicin in patients with STS Ended

2024-512789-32-00 Unresectable or metastatic soft tissue sarcoma 5 2017-10-09
CRITICS-II Ended

2023-503248-15-00 Patients with TNM 8th ed stage IB-IIC gastric adenocaci 4 2017-10-09
International trial in Philadelphia chromosome-positive acute lymphoblastic leukemia Ended

2024-515499-12-00 Acute lymphoblastic leukemia 5 2017-10-02
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib Ended

2023-507329-40-00 1. Follicular Lymphoma 2. Chronic Lymphocytic Leukemia 6 2017-09-28
A research study to compare the standard treatment and the study drug (degarelix) in combination with radiotherapy in patients with high-ris… Ended

2024-513450-30-00 very high risk localized or locally advanced prostate c 5 2017-09-25
A Phase 1/2 study on the effects of LOXO-292 (study drug) in patients with advanced solid tumors. Ended

2023-507702-13-00 Male or female patients age 12 years or older with a lo 7 2017-09-22
Randomized trial of avelumab-cetuximab-Radiotherapy versus standards of care in the head and neck cancers Ended

2024-513964-24-00 Squamous cell carcinoma, previously untreated Stage III 5 2017-09-14
An Extension and Long-Term Observational Study In Patients Previously Enrolled in a Genentech− and/Or F. Hoffmann-La Roche Ltd−Sponsored Ate… Ended

2023-506186-57-00 Cancer (Future parent protocols may include other cance 5 2017-09-04
A study of TG4001 and avelumab cancer immunotherapies in advanced HPV-induced malignancies Ended

2024-515119-23-00 Phase Ib and Phase II part 1: HPV-16 positive recurrent 9 2017-08-29
A Study Evaluating the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Patients with Advanced or Metastatic Non-Small C… Ended

2023-507500-31-00 Advanced or metastatic Non-small cell lung cancer (NSCL 10 2017-08-22
„INSIGHT“ An explorative, open-labeled, phase I trial to evaluate feasibility and safety of eftilagimod alpha (IMP321, a LAG-3Ig fusion prot… Ended

2024-516026-56-00 Histologically confirmed locally advanced or metastatic 3 2017-08-17
A Phase III double-blind placebo-controlled Randomised Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients Ended

2022-502798-40-00 Patients with resected colon carcinoma 5 2017-07-31
Brentuximab vedotin+Adriamycin, vinblastine, and dacarbazine in pediatric patients with advanced stage newly diagnosed Hodgkin lymphoma Ended

2023-506415-18-00 Hodgkin lymphoma (HL) - Hodgkin lymphoma (HL), a neopla 9 2017-07-18
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Bendamustine and Rituximab (BR) Alone Versus in Combination wi… Ended

2023-509354-58-00 Mantle Cell Lymphoma 5 2017-07-14
B-NHL 2013 - Treatment protocol of the NHL-BFM and the NOPHO study groups for mature aggressive B-cell lymphoma and leukemia in children and… Ended

2023-505509-18-00 mature aggressive B-cell lymphoma and leukemia in child 5 2017-07-12
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer (monarchE) Ended

2023-509671-17-00 Breast Cancer 5 2017-07-12
Study with investigational drug PF-06463922 and comparator crizotinib in patients with a specific type of advanced lung cancer Ended

2023-509169-19-00 Advanced ALK positive non-small cell lung cancer 5 2017-07-11
Chemotherapy-free trastuzumab and pertuzumab in HER2-positive breast cancer after FDG-PET response-adapted strategy. The PHERGain study Ended

2023-509923-42-00 HER2- positive breast cancer 4 2017-07-06
S1404: A Phase III Randomized Trial Comparing Physician/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizuma… Ended

2024-516881-12-00 High risk resected melanoma. 5 2017-07-05
Study to allow patients with cMET-dependent malignancies to continue capmatinib treatment Ended

2024-510948-31-00 cMET-dependent malignancies 4 2017-07-04
Comparison FOLFIRINOX Panitumumab vs mFOLFOX6 Panitumumab in RAS/B-RAF Wild-type Metastatic Colorectal Cancer Patients (PANIRINOX) Ended

2024-510645-34-00 RAS and B-RAF wild-type metastatic colorectal cancer. R 4 2017-06-28
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an anti-PD-1 Monoclonal Antibody, in Patients with Advanced Solid Tumors Ended

2023-506390-35-00 Patients with Advanced Solid Tumors 1 2017-04-19
A study to test the safety and efficacy of the drug larotrectinib for the treatment of tumors with NTRK-fusion in children Ended

2022-502668-20-00 Solid tumors harboring NTRK fusion 9 2017-04-11
IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting Ended

2024-517489-41-00 High-risk stage III colon cancer 5 2017-03-27